Form 4: Core Laboratories Director Martha Z. Carnes Reports Stock Transactions
SEC Form 4
Director Martha Z. Carnes reports acquisition and disposal of Core Laboratories Inc. common stock and restricted shares on April 1, 2024.
Summary
- On April 1, 2024, Martha Z. Carnes, a director of Core Laboratories Inc., engaged in transactions involving the company's stock.
- Carnes acquired 6,419 shares of common stock and 9,317 restricted shares.
- She also disposed of 6,419 shares of common stock.
- Following these transactions, Carnes directly owns 37,011 shares of common stock and 9,317 restricted shares.
- The restricted shares acquired on April 1, 2024, will vest on April 1, 2025.
- Restricted shares vested at the end of a one-year vesting period ending April 1, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions by a company director, with neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company insider.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of stock transactions (acquisition and disposal of common stock and restricted shares). |
| 04/01/2025 | Vesting date for the restricted shares acquired on April 1, 2024. |
| 04/02/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.